Celltrion Healthcare
Scope
Date
~
-
Carbon neutrality
Samsung Biologics, Celltrion pledge major CO2 cuts
South Korea’s No. 1 biopharmaceutical company Samsung BioLogics Co. and No. 2 Celltrion Inc. produced higher CO2 emissions last year than in 2...
Jul 10, 2023 (Gmt+09:00)
-
Venture capital
Ontario, S.Korea VC firm to establish $76 mn healthcare fund
Canada's Ontario government has joined hands with a South Korean venture capital firm to establish a fund of 100 million Canadian dollars ($75.6 mil...
Jul 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches Humira biosimilar Yuflyma in US
South Korean biopharmaceutical company Celltrion Healthcare on Monday said it launched the day before on the US market Yuflyma, a biosimilar of the ...
Jul 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Metaverse
Kakao Healthcare to build metaverse healthcare platform
Kakao Healthcare, a digital healthcare platform unit of South Korea's Kakao, announced on Wednesday that it has been selected as the final operato...
Jun 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Kakao Healthcare ties up with Dexcom for global diabetes biz
South Korea’s Kakao Healthcare Corp. has taken a step forward to expand its business into the global market by collaborating with US medical d...
Jun 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion puts Takeda’s assets up for sale after 3 years
South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...
Jun 18, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm’s Cenobamate gets nod in Canada, to boost US sales
South Korea’s SK Biopharmaceuticals Co. has obtained the sales approval for its antiepileptic treatment Cenobamate in Canada, paving the way f...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US
South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
-
Healthcare
S.Korea to seek expansion of healthcare package export
South Korean government has set a goal to expand medical service exports by attracting 700,000 foreign patients and receiving 70 applications of ove...
Jun 05, 2023 (Gmt+09:00)
-
Korean startups
Bredis Healthcare, Tilda win June D.Day, Korea’s oldest startup pitch race
An early-stage startup by young entrepreneurs who developed a digital diagnostic tool for brain disease and an AI-powered business optimization prog...
Jun 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to develop Humira biosimilar oral medication with US firm
South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...
Jun 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima SC praised in Europe as preferred biosimilar
MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...
Jun 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe
South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
CrystalGenomics to sell largest 20% stake to Invites Healthcare for $44 mn
CrystalGenomics Inc., South Korea’s first-generation biopharma venture company, will sell new shares worth 58 billion won ($44 million) in a b...
May 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches Remsima SC in Brazil
South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...
May 22, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
KT to open medical checkup center in Hanoi, Vietnam
South Korea's KT Corp. next year will launch a medical checkup center in Hanoi, Vietnam, under a strategy to advance its digital healthcare business...
May 15, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion drops bid to acquire Baxter’s biopharm unit
Celltrion Inc. announced on Tuesday it has decided not to pursue the acquisition of the biopharmaceutical unit of U.S. medical device maker Baxter I...
May 09, 2023 (Gmt+09:00)
-
Korean startups
S.Korean startups eye on Southeast Asia as promising market
SINGAPORE - Southeast Asia with a youth population constituting about one-third of the region’s total population and surging internet penetrat...
May 08, 2023 (Gmt+09:00)
-
Korean stock market
Defense, healthcare lure global funds in dull market
Defense, healthcare and semiconductor materials companies have been the main investment targets of global funds such as Fidelity and Morgan Stanley ...
May 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for Phase 3 clinical trials in Europe for biosimilar
South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Kakao Healthcare teams up with US digital, biohealth firms
Kakao Healthcare, a digital healthcare platform unit of South Korea's Kakao Group, has teamed up with US digital and health companies such as DexCom...
Apr 28, 2023 (Gmt+09:00)
-
Korean startups
S.Korean walking app Cashwalk debuts in Spain, Italy
Nudge Healthcare, a South Korean startup that operates the health management app Cashwalk, has added Italy and Spain to the list of overseas markets...
Apr 27, 2023 (Gmt+09:00)
-
Korean SMEs
S.Korea gov’t hosts sales event for domestic, US SMEs
South Korean small- and medium-sized enterprises (SMEs) expanded their exchange and cooperation with US firms during President Yoon Suk yeol's state...
Apr 26, 2023 (Gmt+09:00)
-
Private equity
More Korean LPs look to buyouts, special situations for private equity
Healthcare continued to be the preferred sector for South Korean institutional investors this year as it was last year, a survey found. Meanwhile, the...
Apr 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare enters top 10 in hospital prescriptions in Turkey
South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...
Apr 21, 2023 (Gmt+09:00)
-
Healthcare
Samsung unveils HealthStack at US healthcare tech exhibition
Samsung Electronics Co. announced on Tuesday that it will showcase Samsung HealthStack ver. 1.0 at the "2023 HIMSS Global Health Conference & Ex...
Apr 18, 2023 (Gmt+09:00)